Old Web
English
Sign In
Acemap
>
authorDetail
>
Aurelia Haller
Aurelia Haller
Takeda Pharmaceutical Company
Immunology
Virology
Dengue vaccine
Dengue fever
Vaccination
3
Papers
131
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
2014
Lancet Infectious Diseases
Jorge E. Osorio
Iván Darío Vélez
Cynthia A. Thomson
Liliana Lopez
Alejandra Jiménez
Aurelia Haller
Shawn Silengo
Jaclyn Scott
Karen L. Boroughs
Janae L. Stovall
Betty E. Luy
John Arguello
Mark E Beatty
Joseph D. Santangelo
Gilad Gordon
Claire Y.-H. Huang
Dan T. Stinchcomb
Show All
Source
Cite
Save
Citations (107)
A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
2014
Frontiers in Immunology
Yuping Ambuel
Ginger R. Young
Joseph N. Brewoo
Joanna Paykel
Kim L. Weisgrau
Eva G. Rakasz
Aurelia Haller
Michael Royals
Claire Y.-H. Huang
Saverio Capuano
Dan T. Stinchcomb
Charalambos D. Partidos
Jorge E. Osorio
Show All
Source
Cite
Save
Citations (23)
Preclinical Evaluation of a Live Attenuated Chikungunya Vaccine
2012
Procedia in Vaccinology
Jill A. Livengood
Charalambos D. Partidos
Kenneth Plante
Robert L. Seymour
Rodion Gorchakov
Laszlo Varga
Joanna Paykel
James Weger
Aurelia Haller
Dan T. Stinchcomb
Jorge E. Osorio
Scott C. Weaver
Show All
Source
Cite
Save
Citations (1)
1